| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9002068 | Biochemical Pharmacology | 2005 | 6 Pages |
Abstract
Hetastarch treatment delayed myocardial edema development and attenuated myocardial creatine kinase efflux, thereby preserving diastolic function.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology
Authors
James A. Jr., Daniel C. Sigg, Paul A. Iaizzo,